Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia

References

1. Spencer R. C. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30: Suppl 453–164
   [Google Scholar]
2. Gardner P., Griffin W. B., Swartz M. N., Kunz L. J. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med 1970; 48:735–749
   [Google Scholar]
3. Kerr J. R. Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J Clin Microbiol 1994; 32:525–527
   [Google Scholar]
4. Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infect 1994; 28:305–310
   [Google Scholar]
5. Gillies R. R., Govan J. R. W. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol 1966; 91:339–345
   [Google Scholar]
6. Caticha O., Grover S., Winge D., Odell W. D. Stimulation of Candida albicans transition by human chorionic gonadotropin and a bacterial protein. Endocr Res 1992; 18:133–143
   [Google Scholar]
7. Elander R. P., Mabe J. A., Hamill R. H., Gorman M. Metabolism of tryptophans by Pseudomonas aureofaciens. VI. Production of pyrrolnitrin by selected Pseudomonas species. Appl Microbiol 1968; 16:753–758
   [Google Scholar]
8. Zhou P., Mocek U., Siesel B., Floss H. G. Biosynthesis of pyrrolnitrin. Incorporation of 13C, 15N double labelled D- and L-tryptophan. J Basic Microbiol 1992; 32:209–214
   [Google Scholar]
9. Arima K., Imanaka M., Kousaka M., Fukuta A., Tamura G. Pyrrolnitrin, a new antibiotic substance produced by Pseudomonas. Agr Biol Chem 1964; 28:575–576
   [Google Scholar]
10. Cohen R., Roth F. J., Delgado E., Ahearn D. G., Kaiser M. H. Fungal flora of the normal human small and large intestine. N Engl J Med 1969; 280:638–641
    [Google Scholar]
11. Govan J. R. W. Pseudomonas. In Collee J. G., Duguid J. P., Fraser A. G., Marmion B. P. Practical medical microbiology Edinburgh: Churchill Livingstone; 1989491–504
    [Google Scholar]
12. Govan J. R. W., Nelson J. W. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992; 48:912–930
    [Google Scholar]
13. Gordee R. S., Matthews T. R. Evaluation of the in vitro and in vivo antifungal activity of pyrrolnitrin. Antimicrob Agents Chemother 1967; 7:378–387
    [Google Scholar]
14. Valsecchi R., Foiadelli L., Cainelli T. Contact dermatitis from pyrrolnitrin. Contact Dermatitis 1981; 7:340
    [Google Scholar]